Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | 4.53 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | 2.64 | 3.92 | 1.28 | 48.48% |
2024-04-30 | 2024-03 | 2.53 | 2.58 | 0.05 | 1.98% |
2024-02-06 | 2023-12 | 2.47 | 2.49 | 0.02 | 0.81% |
2023-11-02 | 2023-09 | -0.08 | 0.1 | 0.18 | 225.00% |
2023-08-08 | 2023-06 | 1.98 | 2.11 | 0.13 | 6.57% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-08 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-09-15 | ALVAREZ RALPH | Director | 54.25K | Stock Award(Grant) |
2024-08-11 | HAKIM ANAT | General Counsel | 30.48K | Stock Gift |
2024-09-15 | HEDLEY MARY LYNNE | Director | 1.64K | Stock Award(Grant) |
2024-09-15 | JOHNSON KIMBERLY H | Director | 2.69K | Stock Award(Grant) |
2024-09-02 | LILLY ENDOWMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 96.89M | Sale |
2024-09-15 | LUCIANO JUAN R | Director | 15.81K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Lilly Endowment, Inc | 99.98M | 53.70B | 10.53% |
2023-06-29 | Vanguard Group Inc | 69.92M | 32.79B | 7.37% |
2023-06-29 | Blackrock Inc. | 64.45M | 30.23B | 6.79% |
2023-06-29 | PNC Financial Services Group, Inc. | 51.87M | 24.33B | 5.46% |
2023-06-29 | State Street Corporation | 33.88M | 15.89B | 3.57% |
2023-06-29 | FMR, LLC | 32.80M | 15.38B | 3.46% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 26.65M | 12.50B | 2.81% |
2023-06-29 | Vanguard 500 Index Fund | 18.76M | 8.80B | 1.98% |
2023-06-29 | Vanguard/Primecap Fund | 13.35M | 6.26B | 1.41% |
2023-05-30 | Fidelity 500 Index Fund | 8.83M | 3.79B | 0.93% |
2023-08-30 | SPDR S&P 500 ETF Trust | 8.68M | 4.81B | 0.91% |
2023-08-30 | iShares Core S&P 500 ETF | 7.37M | 4.08B | 0.78% |
Dividend | Date |
---|---|
1.3 | 2024-08-15 |
1.3 | 2024-05-15 |
1.3 | 2024-02-15 |
1.3 | 2024-02-14 |
1.13 | 2023-11-14 |
1.13 | 2023-09-08 |
Split | Date |
---|---|
2 : 1 | 1997-10-16 |
2 : 1 | 1995-12-21 |
2 : 1 | 1989-05-01 |
2 : 1 | 1986-01-30 |
-
Be careful $LLY can fall to $260 suddenly any next second!
-
Blockbuster Diabetes drug injectable Mounjaro just approved by FDA with significant weight loss. Also undergoing trials for obese people without diabetes with results comparable to gastric bypass. Been buying dip on Wed., Today and more on Friday. This is a breakout drug that will bring in billions of new profits.
-
-
-
Eli Lilly to enter licence agreement for novel CX3CR1 inhibitor, undertake responsibility for clinical development, commercialization?
-
Sorrento therapeutics
-
Less dose! 10times as potent ! Don’t need infusion
-
Sorrento is better
-
-
-
My hospital is pumping this med $LLY gonna be a billionaire beat
-
They know Sorrento is better and less dosage
-
But $SRNE has the most Potent cocktail
-
Hmmmm something is going to blow
-
Regeneron already has rights to it
-
Maybe lily owns the bar but sell srne?
-
But $SRNE has a better cocktail???????
-
$SRNE is a better product
-
-
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
Prediction: This Will Be the Biggest Pharma Stock in 10 Years
247wallst.com • -
Prediction: This Will be Eli Lilly's Next Big Move.
news.google.com • -
Eli Lilly & Co. stock outperforms competitors despite losses on the day
news.google.com • -
ResMed stock cut at Wolfe on Lilly GLP-1 threat (NYSE:RMD)
news.google.com • -
ResMed stock cut at Wolfe on Lilly GLP-1 threat (NYSE:RMD)
news.google.com • -
December 20th Options Now Available For Eli Lilly (LLY)
news.google.com • -
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
news.google.com • -
Looking Into Eli Lilly's Recent Short Interest
news.google.com • -
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
news.google.com • -
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
news.google.com • -
Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?
news.google.com • -
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
Lilly Gets FDA Approval for Eczema Drug Ebglyss
zacks.com • -
Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025
news.google.com • -
Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025
news.google.com • -
(LLY) Long Term Investment Analysis
news.google.com • -
Do queasy side effects mean the end of weight-loss drug stock hype?
news.google.com • -
Is Eli Lilly and Company (LLY) an Unstoppable Dividend Stocks to Buy?
news.google.com • -
Eli Lilly and Co (LLY) Stock Price, Trades & News
news.google.com • -
3 Stocks to Buy and Hold Forever
fool.com • -
US FDA approves Eli Lilly's eczema drug
reuters.com • -
6 Incredible Reasons to Invest in Eli Lilly
fool.com • -
Eli Lilly stock gains as Citi resumes at buy (NYSE:LLY)
news.google.com • -
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
Eli Lilly Invests $1.8B To Expand Drug Output in Ireland
investopedia.com • -
NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise
news.google.com • -
Five Top Obesity Stocks to Buy and Hold Long Term
247wallst.com • -
Bull of the Day: Eli Lilly (LLY)
news.google.com • -
2 Weight Loss Drug Stocks Worth Stashing Away for Years
247wallst.com •